Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics 2016

Publisher: La Merie Publishing
Pages: 34
Format: PDF and Online
Product Line:
Competitor Analysis
Product Code: LMCA0137
Release Date: June of 2016

250.00 €
Free of 19 % VAT (except in Germany and also in the European Union without valid intl. VAT no),
Delivery costs do not apply or are included.
License:
You can also order this product via email or fax , please download the Order Form
Need more information?
Ask a question about this product

Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics 2016

This Competitive Intelligence Report about prophylaxis and therapy of Clostridium difficile infections provides a competitor evaluation in the field of new molecules or microorganisms for prevention or treatment of Clostridium difficle infections as of June 2016. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of antibodies, proteins, peptides, vaccines, microorganisms, antibiotics and small molecules for prevention and  treatment of Clostridium difficile infections. In addition, the report lists company-specific R&D pipelines of C. difficile vaccines and therapeutics. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics 2016

Table of Contents

1) C. Difficile Vaccines

2) C. Difficile Therapeutics:

  • Antibodies
  • Microbiome-based
  • Anti-Infective Peptides
  • Antibiotics
  • Others

3) Corporate C. Difficile Vaccines & Therapeutics R&D Pipeline

 



The above shown price refers to a Single User License. Please contact us for prices of departmental, site or global product licenses.

This Report is NOT a downloadable item but will be delivered via email within 24 h (working days only).

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top